We are live on ! Find out more
OBCI

Ocean Bio-Chem Inc

Delisted

OBCI was delisted on the 8th of August, 2022.

15 hedge funds and large institutions have $1.75M invested in Ocean Bio-Chem Inc in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

0% more funds holding

Funds holding: 1515 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

8% less capital invested

Capital invested by funds: $1.89M → $1.75M (-$147K)

Holders
15
Holders Change
Holders Change %
0%
% of All Funds
0.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

OBCI Hedge Fund Activity: Q4 2017 in Review

15 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Ocean Bio-Chem Inc (OBCI) for Q4 2017, worth a combined $1.75M — down 7.8% from $1.89M a quarter earlier.

Fund positioning in OBCI was balanced in Q4 2017: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $99.9K. The largest seller was Shepherd Kaplan Krochuk, cutting an estimated $74.1K.

  • 15 institutional investors held Ocean Bio-Chem Inc (OBCI) as of Q4 2017, unchanged from Q3 2017.
  • Funds reported $1.75M of Ocean Bio-Chem Inc stock for Q4 2017, down 7.8% quarter-over-quarter.
  • 2 funds opened new Ocean Bio-Chem Inc positions in Q4 2017 and 2 closed out, a net change of 0 holders.
  • The largest Ocean Bio-Chem Inc buyer in Q4 2017 was Renaissance Technologies, an estimated $99.9K added.
  • The largest Ocean Bio-Chem Inc seller in Q4 2017 was Shepherd Kaplan Krochuk, an estimated $74.1K sold.

Based on aggregated 13F filings for Q4 2017.